Techpool Bio-Pharma Co., Ltd. engages in researching, developing, manufacturing, and marketing bio-pharmaceutical products. It offers finished products, including chorionic gonadotropin for injection, low molecular weight heparin calcium injection, urokinase for injection, ulinastatin for injection, iron sucrose injection, and galanthamine hydrobromide tablets. The company also provides active pharmaceutical ingredients, such as human urine source, animal organ source, plant source, and chemical synthesis. It offers its products in the United States, the United Kingdom, Germany, Italy, Switzerland, France, Japan, Korea, and internationally.

Company was acquired by Takeda Pharmaceuticals International GmbH